Digital tools to measure Parkinson disease

Slides:



Advertisements
Similar presentations
Study Design 121 Relapsing-remitting MS patients randomized to –Stress Management Therapy MS active treatment* 16 individual sessions conducted over 24.
Advertisements

Intermediate CAG repeats: Analysis of the Cooperative Huntington’s Observational Research Trial (COHORT) Ainhi D. Ha, MBBS 1, Christopher A. Beck, PhD.
Digital Health: Connecting Your Medicines to the Internet Means Better Care at Lower Cost George M. Savage, MD Cofounder & Chief Medical Officer May 2,
Scaling Personal Stress Assistance in the Natural Environment Santosh Kumar, University of Memphis.
ALS Monitoring and Analysis System 26/3/2015 IATI MNC 3 rd Weekathon Demo Igor Shishkin, Moshe Taieb, Ran Mizrachi, Limor Lahiani, Nir Levy, Lilach Tesler.
Scientific literacy- Module II, April 10, Jim Kennedy - Example of critical review of a paper Cobo et al, 2007 Sensitivity and specificity of culture.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
Home Health Care and Assisted Living Professor John A. Stankovic Department of Computer Science University of Virginia.
Supportive Slides Alzheimer Disease Assessment Scale—Cognitive Subscale (ADAS-cog) 11-Item Score range Memory and new learning Word recall (mean.
A 68 year old woman with a troublesome chin tremor Teaching NeuroImages Neurology Resident and Fellow Section © 2013 American Academy of Neurology.
10 Second Case Studies Round 2: Degenerative Neurological Conditions.
Depression and Parkinson Disease: An Old Drug Still Works (Better) Summary and Comment by Jonathan Silver, MD Published in Journal Watch Psychiatry February.
Using Lifestyle Monitoring to Predict Bipolar Episodes Rachel Heath School of Psychology University of Newcastle, Australia SykTek ®
The Goal Use computers to aid physicians in diagnosis of neurological diseases, particularly epilepsy Detect pathological events in real time Currently,
Nervous System Diseases & Disorders Notes. Head Trauma #1 cause of trauma deaths in US Many possible mechanisms of injury: Falls Motor vehicle crashes.
47-year-old with progressive upper limb weakness Teaching NeuroImages Neurology Resident and Fellow Section © 2014 American Academy of Neurology.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
The Occupational Therapist and Huntington’s Disease
Neurological Disorders
PRESENTATION CSE 341 MICROPROCESSOR Presented By Nabid Kaisar
The Next Generation of Research and Care
Healthcare and Medicine: New frontiers for analytics and data mining
Gadgets in health it Convergence of Wellness and Wireless
Concordance Of Clinical & Electronic Data In Assessment of Depression: Findings From The Smartphone And Online Usage Based Evaluation For Depression (SOLVD)
Voice Disorders Clinical Applications Chapter 6
Best Viewed on PPT 2016.
Swallowing function in people with Friedreich ataxia Megan J Keage a, Louise Corbenb , Martin Delatyckib & Adam P. Vogela Swal-QOL items (total) FRDA.
Figure 1 Sleep duration in our patient population according to the National Sleep Foundation recommendations (N = 61). From: Screening for Insomnia: An.
Mihail Popescu, PhD; Andrew Craver, MS, MPH
Spes Spirae - A project to make accurate measurements relevant for Parkinson’s disease on a big scale Spesspirae.com
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Long Term Effects of Concussions
The Effects of Aerobic Exercise on Motor and Non-motor Symptoms of Parkinson’s Disease Michelle Costa Professor Frank Wang, MS, MBA Sacred Heart University.
Figure EDSS, FS scores, and Modified MSFC scores
Elham Rastegari University of Nebraska at Omaha
The Psychiatric GWAS Consortium: Big Science Comes to Psychiatry
Figure 2 ALSFRS-R changes (A) Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) slope after 6 months of treatment without (left)
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Figure 2 Disease progression slowed during each round of Treg infusions and correlated with increased Treg suppressive function Disease progression slowed.
Figure 1 Allele frequency and effect size for ALS-associated genes
Figure 1 Patient flow diagram
Amol Rajmane, MD, MS, MBA Associate Director,
Updates in the Management of Parkinson's Disease Psychosis
Figure 3 Genetic pleiotropy in ALS
Rise and fall of myoglobin and creatine kinase (CK) during the course of rhabdomyolysis. Rise and fall of myoglobin and creatine kinase (CK) during the.
Why Does Knowing How to Find the Best Evidence Matter?
Axon Registry: Background
Figure 2 Primary and secondary outcomes reported in multiple sclerosis (MS) disease-modifying therapy (DMT) clinical trials Primary and secondary outcomes.
A Sequel to the Tale of p25/Cdk5 in Neurodegeneration
Figure 3 Temporal trends in FALS incidence
by Gail N Hayward, Charles Vincent, and Daniel S Lasserson
A Review of the Evidence for Medical Cannabis Based on Approved Conditions in Iowa Authors: Ryan Molander, Sarah Kadura, spencer smythe, and nickolas Scott.
Frequency of patients in flare at each time point over 3 months
Figure 2: Tasks and the corresponding features explored in the study.
Parkinson’s disease. (A) The spiral of the patient with Parkinson’s disease (right) is smaller than the clinician’s, with tighter turns. Parkinson’s disease. (A)
Reducing antibiotic use in influenza: challenges and rewards
Column bar graphs showing Health Assessment Questionnaire (HAQ) scores and pain score on Visual Analogue Scale (VAS) (scale 0–10) that were collected at.
Figure 2. Patient stratification by the reported duration of symptoms and disease severity at the time of assessment Patient stratification by the reported.
Figure 4. The N:M ratio is significantly increased in patients with ALS and correlates with disease progression The N:M ratio is significantly increased.
Introduction: Evolution of military and veterans brain health research
Proportion of patients in each World Health Organization functional class (WHO-FC) at the time of pulmonary arterial hypertension-associated systemic sclerosis.
Research and teaching, areas
The National Institutes of Allergy and Infectious Diseases networks on asthma in inner- city children: An approach to improved care  William W. Busse,
Suggested algorithm of addressing non-motor symptoms in clinic (modified from Chaudhuri et al).48 HCP, healthcare professional; QoL, quality of life; PDSS,
Number of patients treated at clinics that followed up fewer than 10 patients (2013–2016) or 20 patients (2012) and proportion of patients followed up.
Cost-effectiveness acceptability frontier for three risk-assessment strategies related to pressure-injury prevention best practices from a US societal.
Regions showing progression of GM atrophy during a 9-month period90 in 16 patients with ALS compared with 10 controls (red) and regions showing additional.
Figure 2. Percentage of CD16− monocytes in the blood is reduced during disease progression Percentage of CD16− monocytes in the blood is reduced during.
Occurrence of falls and depressive symptoms on the basis of the set of risk factors (poor self rated health, poor cognitive status, impaired ADL, two or.
Presentation transcript:

Digital tools to measure Parkinson disease

Our perspective of a patient’s illness experience remains episodic and limited to the clinic Number of falls throughout day Proportion of day spent sedentary Heart rate variability Number of words spoken Speed of dialing the phone Unified Parkinson’s Disease Rating Scale Time spent outside Number of sleep interruptions Unified Huntington’s Disease Rating Scale Duration of sleep Amyotrophic Lateral Sclerosis Functional Rating Scale Activity level Alzheimer’s Disease Assessment Scale Number of turns Timed Up and Go

The use of technology to measure health is rapidly growing Published studies of wearable sensors and smartphones in Neurology through Dec. 2017 Wearable sensors Smartphones A graph showing the volume of published studies of smartphones and wearable sensors for neurological conditions from 1992-2017. Smartphone studies are in black; wearable sensor studies are in orange. Few studies were conducted prior to 2015, but the number has since increased exponentially. Source: PubMed searches of smartphone and wearable sensor studies for neurology and associated conditions on 12/31/2017

Not only can sensors track known motor symptoms over time… Frequency and severity of tremor detected over one hour period Preliminary

… …they can also capture novel data objectively and continuously in clinic “This could be the first time that such an app has been used to measure disease and symptom severity in a medicine development program in Parkinson’s disease.” Source: Lindemann et al., 2017

We are in the midst of a Parkinson Pandemic Source: The Parkinson Pandemic: a call to action. JAMA Neurology 2017